Charuhas Deshpande
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 2%
- Immunology top 2%
- Biomedical Engineering top 5%
- Molecular Biology
- Co-authors
- Sunil SinghalSteven Μ. AlbeldaLeslie A. LitzkyEvgeniy EruslanovPratik BhojnagarwalaJon G. QuatromoniMichael D. FeldmanJosé R. Conejo-García
- Topics
- Lung Cancer Diagnosis and Treatment (16 papers)Nanoplatforms for cancer theranostics (10 papers)Lung Cancer Treatments and Mutations (8 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Charuhas Deshpande
58 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 1.1k
- Immunology 954
- Biomedical Engineering 569
- Molecular Biology 486
Countries citing papers authored by Charuhas Deshpande
This map shows the geographic impact of Charuhas Deshpande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charuhas Deshpande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charuhas Deshpande more than expected).
Fields of papers citing papers by Charuhas Deshpande
This network shows the impact of papers produced by Charuhas Deshpande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charuhas Deshpande. The network helps show where Charuhas Deshpande may publish in the future.
Co-authorship network of co-authors of Charuhas Deshpande
This figure shows the co-authorship network connecting the top 25 collaborators of Charuhas Deshpande. A scholar is included among the top collaborators of Charuhas Deshpande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charuhas Deshpande. Charuhas Deshpande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 93 | |
| 6 | 2 | |
| 7 | 65 | |
| 8 | 102 | |
| 9 | 53 | |
| 10 | 334 | |
| 11 | 30 | |
| 12 | 56 | |
| 13 | 75 | |
| 14 | 135 | |
| 15 | 21 | |
| 16 | 22 | |
| 17 | 13 | |
| 18 | 112 | |
| 19 | 60 | |
| 20 | 1 |
About Charuhas Deshpande
Charuhas Deshpande is a scholar working on Microbiology, Pulmonary and Respiratory Medicine and Oncology, having authored 60 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Nanoplatforms for cancer theranostics (10 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Immunology (954 citations), Oncology (1.1k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Charuhas Deshpande has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Sunil Singhal, Steven Μ. Albelda, Leslie A. Litzky, Evgeniy Eruslanov, Pratik Bhojnagarwala, Jon G. Quatromoni, Michael D. Feldman, José R. Conejo-García, Wayne W. Hancock and Tom L. Stephen. Their work appears in journals such as Nature, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.